Literature DB >> 25791526

The role of formylated peptides and formyl peptide receptor 1 in governing neutrophil function during acute inflammation.

David A Dorward1, Christopher D Lucas2, Gavin B Chapman2, Christopher Haslett2, Kevin Dhaliwal2, Adriano G Rossi2.   

Abstract

Neutrophil migration to sites of inflammation and the subsequent execution of multiple functions are designed to contain and kill invading pathogens. These highly regulated and orchestrated processes are controlled by interactions between numerous receptors and their cognate ligands. Unraveling and identifying those that are central to inflammatory processes may represent novel therapeutic targets for the treatment of neutrophil-dominant inflammatory disorders in which dysregulated neutrophil recruitment, function, and elimination serve to potentiate rather than resolve an initial inflammatory insult. The first G protein-coupled receptor to be described on human neutrophils, formyl peptide receptor 1 (FPR1), is one such receptor that plays a significant role in the execution of these functions through multiple intracellular signaling pathways. Recent work has highlighted important observations with regard to both receptor function and the importance and functional relevance of FPR1 in the pathogenesis of a range of both sterile and infective inflammatory conditions. In this review, we explore the multiple components of neutrophil migration and function in both health and disease, with a focus on the role of FPR1 in these processes. The current understanding of FPR1 structure, function, and signaling is examined, alongside discussion of the potential importance of FPR1 in inflammatory diseases suggesting that FPR1 is a key regulator of the inflammatory environment.
Copyright © 2015 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25791526      PMCID: PMC4419282          DOI: 10.1016/j.ajpath.2015.01.020

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  111 in total

1.  Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1.

Authors:  Mustafa Raoof; Qin Zhang; Kiyoshi Itagaki; Carl J Hauser
Journal:  J Trauma       Date:  2010-06

Review 2.  Breaching multiple barriers: leukocyte motility through venular walls and the interstitium.

Authors:  Sussan Nourshargh; Peter L Hordijk; Michael Sixt
Journal:  Nat Rev Mol Cell Biol       Date:  2010-05       Impact factor: 94.444

Review 3.  Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists.

Authors:  Neil Dufton; Mauro Perretti
Journal:  Pharmacol Ther       Date:  2010-06-08       Impact factor: 12.310

4.  Formyl peptide receptor ligands promote wound closure in lung epithelial cells.

Authors:  Guohong Shao; Mark W Julian; Shengying Bao; Meghan K McCullers; Ju-Ping Lai; Daren L Knoell; Elliott D Crouser
Journal:  Am J Respir Cell Mol Biol       Date:  2010-10-01       Impact factor: 6.914

5.  Intravascular danger signals guide neutrophils to sites of sterile inflammation.

Authors:  Braedon McDonald; Keir Pittman; Gustavo B Menezes; Simon A Hirota; Ingrid Slaba; Christopher C M Waterhouse; Paul L Beck; Daniel A Muruve; Paul Kubes
Journal:  Science       Date:  2010-10-15       Impact factor: 47.728

6.  Circulating mitochondrial DAMPs cause inflammatory responses to injury.

Authors:  Qin Zhang; Mustafa Raoof; Yu Chen; Yuka Sumi; Tolga Sursal; Wolfgang Junger; Karim Brohi; Kiyoshi Itagaki; Carl J Hauser
Journal:  Nature       Date:  2010-03-04       Impact factor: 49.962

7.  Mitochondrial damage associated molecular patterns from femoral reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase.

Authors:  Carl J Hauser; Tolga Sursal; Edward K Rodriguez; Paul T Appleton; Qin Zhang; Kiyoshi Itagaki
Journal:  J Orthop Trauma       Date:  2010-09       Impact factor: 2.512

8.  Polymorphisms of the formylpeptide receptor gene (FPR1) and susceptibility to stomach cancer in 1531 consecutive autopsy cases.

Authors:  Tatsuro Otani; Shinobu Ikeda; Htay Lwin; Tomio Arai; Masaaki Muramatsu; Motoji Sawabe
Journal:  Biochem Biophys Res Commun       Date:  2011-01-07       Impact factor: 3.575

9.  Inhibition of human peptide deformylase disrupts mitochondrial function.

Authors:  Sindy Escobar-Alvarez; Jeffrey Gardner; Aneesh Sheth; Giovanni Manfredi; Guangli Yang; Ouathek Ouerfelli; Mark L Heaney; David A Scheinberg
Journal:  Mol Cell Biol       Date:  2010-08-30       Impact factor: 4.272

10.  The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells.

Authors:  J Huang; K Chen; J Chen; W Gong; N M Dunlop; O M Z Howard; Y Gao; X-w Bian; J M Wang
Journal:  Br J Cancer       Date:  2010-03-02       Impact factor: 7.640

View more
  82 in total

Review 1.  New development in studies of formyl-peptide receptors: critical roles in host defense.

Authors:  Liangzhu Li; Keqiang Chen; Yi Xiang; Teizo Yoshimura; Shaobo Su; Jianwei Zhu; Xiu-wu Bian; Ji Ming Wang
Journal:  J Leukoc Biol       Date:  2015-12-23       Impact factor: 4.962

2.  4-Aroyl-3-hydroxy-5-phenyl-1H-pyrrol-2(5H)-ones as N-formyl peptide receptor 1 (FPR1) antagonists.

Authors:  Liliya N Kirpotina; Igor A Schepetkin; Andrei I Khlebnikov; Olga I Ruban; Yunjun Ge; Richard D Ye; Douglas J Kominsky; Mark T Quinn
Journal:  Biochem Pharmacol       Date:  2017-07-08       Impact factor: 5.858

Review 3.  Models of Lung Transplant Research: a consensus statement from the National Heart, Lung, and Blood Institute workshop.

Authors:  Vibha N Lama; John A Belperio; Jason D Christie; Souheil El-Chemaly; Michael C Fishbein; Andrew E Gelman; Wayne W Hancock; Shaf Keshavjee; Daniel Kreisel; Victor E Laubach; Mark R Looney; John F McDyer; Thalachallour Mohanakumar; Rebecca A Shilling; Angela Panoskaltsis-Mortari; David S Wilkes; Jerry P Eu; Mark R Nicolls
Journal:  JCI Insight       Date:  2017-05-04

4.  Mitochondrial damage-associated molecular patterns released by lung transplants are associated with primary graft dysfunction.

Authors:  Davide Scozzi; Mohsen Ibrahim; Fuyi Liao; Xue Lin; Hsi-Min Hsiao; Ramsey Hachem; Laneshia K Tague; Alberto Ricci; Hrishikesh S Kulkarni; Howard J Huang; Seiichiro Sugimoto; Alexander S Krupnick; Daniel Kreisel; Andrew E Gelman
Journal:  Am J Transplant       Date:  2019-01-25       Impact factor: 8.086

5.  Targeting AnxA1/Formyl Peptide Receptor 2 Pathway Affords Protection against Pathological Thrombo-Inflammation.

Authors:  Shantel A Vital; Elena Y Senchenkova; Junaid Ansari; Felicity N E Gavins
Journal:  Cells       Date:  2020-11-13       Impact factor: 6.600

6.  Formyl Peptide Receptor-1 Blockade Prevents Receptor Regulation by Mitochondrial Danger-Associated Molecular Patterns and Preserves Neutrophil Function After Trauma.

Authors:  Kiyoshi Itagaki; Elzbieta Kaczmarek; Woon Yong Kwon; Li Chen; Barbora Vlková; Quanzhi Zhang; Ingred Riça; Michael B Yaffe; Yan Campbell; Michael F Marusich; Ji Ming Wang; Wang-Hua Gong; Ji-Liang Gao; Françoise Jung; Garry Douglas; Leo E Otterbein; Carl J Hauser
Journal:  Crit Care Med       Date:  2020-02       Impact factor: 7.598

7.  Local Generation of Kynurenines Mediates Inhibition of Neutrophil Chemotaxis by Uropathogenic Escherichia coli.

Authors:  Jennifer A Loughman; Melanie L Yarbrough; Kristin M Tiemann; David A Hunstad
Journal:  Infect Immun       Date:  2016-03-24       Impact factor: 3.441

Review 8.  Antagonism of human formyl peptide receptor 1 with natural compounds and their synthetic derivatives.

Authors:  Igor A Schepetkin; Andrei I Khlebnikov; Liliya N Kirpotina; Mark T Quinn
Journal:  Int Immunopharmacol       Date:  2015-09-15       Impact factor: 4.932

9.  The Neutrophil Btk Signalosome Regulates Integrin Activation during Sterile Inflammation.

Authors:  Stephanie Volmering; Helena Block; Mark Boras; Clifford A Lowell; Alexander Zarbock
Journal:  Immunity       Date:  2016-01-05       Impact factor: 31.745

Review 10.  Recent advances into the role of pattern recognition receptors in transplantation.

Authors:  Hrishikesh S Kulkarni; Davide Scozzi; Andrew E Gelman
Journal:  Cell Immunol       Date:  2020-03-07       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.